{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5ebe8cc563e3d811bbd2c9d8/5ebe8f03a8f03f74eeeaa798?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"What is plasma cell leukemia and what are the latest advances in treatment?","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5ebe8cc563e3d811bbd2c9d8/1589546617002-fe8127d1b39ab8ac94a64885bbfaa0ae.jpeg?height=200","description":"<p>During COMy 2020, Artur Jurczyszyn, Jagiellonian University Medical College, Krakow, PL, spoke to the Multiple Myeloma Hub. We asked: What is plasma cell leukemia and what are the latest advances in treatment?</p><p><br></p><p>In this podcast, Artur Jurczyszyn talks about the classifications of plasma cell leukemia and the importance of outlining a plasma cell prognostic index for use in clinical practice. The data from two retrospective analyses, evaluating primary and secondary plasma cell leukemia, are discussed.</p>","author_name":"Scientific Education Support"}